Xcellerant Ventures invested in Lenoss Medical, a Providence, Rhode Island-based provider of an innovative system for the treatment of spinal fractures.
The amount of the deal was not disclosed.
The company intends to use the funds to accelerate its OsteoPearl commercial and development strategies providing physicians a biological option for treating osteoporotic Vertebral Compression fractures.
Led by CEO Dom Messerli, Lenoss is advancing the OsteoPearl VBA System, which leverages minimally invasive and cement-free technology and utilize the natural healing properties of healthy bone to deliver a fully biologic solution to stabilize spinal fractures.
FinSMEs
18/12/2023